| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |